$13.99 $0.15 per serving
Product analysis
Boswellia Extract 500 mg may support joint comfort, but its preparation does not establish a match to those with clearer supporting evidence. The expected benefit remains uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
The named boswellia compounds do not establish clear preparation quality. Their presence alone does not identify a particular extract with established performance.
Ingredient Transparency60
Listed amounts and the boswellia compound names are disclosed. Missing mixture proportions and other unspecified preparations limit a closer comparison.
Value For Money40
Value for the boswellia contribution remains uncertain. A stated extract amount alone does not establish an economical purchase.
Customer Satisfaction92
Customer feedback is very favorable across a large review pool. The volume describes satisfaction without establishing the extract's joint benefits.
Product Focus60
Boswellia gives the formula a clear joint-comfort purpose. Specific extract benefits cannot be assumed from boswellic-acid markers alone.
- Format
Softgel - Container
- 90 Softgel(s)
- Per serving
- $0.15
- Customer rating
- 4.7 · 11,666 ratings
Goals
Impact
Moderate effect
Boswellia · 500 mg
Impact
Moderate effect
Boswellia · 500 mg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 5 Calorie(s) | |
Total Fat | 0.5 Gram(s) | |
Boswellia extract (Boswellic Acid, organic Acids) | 500 mg |
Boswellia (Boswellic Acid, organic Acids) · 500 mg OverallScore30
A serving provides 500 mg of Boswellia serrata gum resin extract, but its boswellic acid percentage is unavailable. That limits comparison of its composition. A separate price-based conclusion for boswellia is unavailable.
How this ingredient is rated
Composition and Label Disclosure0
The boswellic acid percentage is unavailable, so the extract’s marker content is unclear.
Marker and Preparation Disclosure
The boswellic acid percentage is unavailable, so the extract’s marker content is unclear.
Composition and Label Disclosure60
The serving amount is stated, but the boswellic acid percentage is unavailable.
Boswellia Amount and Marker Disclosure
The serving amount is stated, but the boswellic acid percentage is unavailable.
Commercial Price and Usability
A separate price-based conclusion for boswellia is unavailable.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
- Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
- A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
- A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
- Oral herbal therapies for treating osteoarthritis.
- Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
- A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.